Status:
ACTIVE_NOT_RECRUITING
Increasing Access to Breast Cancer Screening Among Immigrants
Lead Sponsor:
Oslo University Hospital
Conditions:
Cancer Screening
Eligibility:
FEMALE
48-73 years
Phase:
NA
Brief Summary
The investigators aim to test whether inviting immigrants to breast cancer screening with a letter in their mother tongue in addition to the standard letter in Norwegian changes screening uptake in th...
Detailed Description
Women in selected immigrant groups according to birth country will be invited to screening and randomized in a 1:1 ratio to receive the screening invitation and information material 1) in the major of...
Eligibility Criteria
Inclusion
- Invited to screening program during the study recruitment period (January 2021-June 2022)
- The registered country of birth of the invitee is one of the following; Poland, Pakistan, Philippines, Somalia, Iraq, Syria, Morocco, Lebanon, Algeria, Egypt, Palestine, Sudan and Tunisia
Exclusion
- Not reached with the screening invitation letter because of wrong address or similar
Key Trial Info
Start Date :
April 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2030
Estimated Enrollment :
11355 Patients enrolled
Trial Details
Trial ID
NCT04672265
Start Date
April 15 2021
End Date
December 31 2030
Last Update
April 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital, Cancer Registry
Oslo, Norway, 0304